$ELF

E.l.f. Beauty (NYSE:ELF) lifts guidance after Rhode accounts for a third of quarterly revenue

E.l.f. Beauty (ELF) raised its fiscal 2027 outlook after reporting fiscal Q1 revenue up 36% to $479.4 million, above the LSEG forecast. Rhode contributed about $160 million, or 33.4% of quarterly sales. The company increased its sales-growth range to 18%-20% and adjusted EBITDA guidance, with margin growth tied largely to tariff refunds.

Original reporting
Published Aug 5, 2026, 10:31 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 6, 2026, 2:11 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
E.l.f. Beauty (NYSE:ELF) lifts guidance after Rhode accounts for a third of quarterly revenue — source image
Decision brief

The 30-second read

$ELFBullishMed
01

Why it matters

The raised fiscal 2027 sales-growth range and adjusted EBITDA guidance are the key tradable catalysts, but the market may reprice risk around margin sustainability and legacy-brand recovery given Rhode’s concentration and tariff-refund dependence.

02

Market read

Traders should focus on whether the market treats the guidance lift as durable operating improvement versus a temporary tariff-refund and Rhode mix effect.

03

What to watch

The article’s organic legacy revenue estimate (implied 9.7% decrease) is not disclosed by the company, and the normalization assumes tariff advantage fully flows into adjusted EBITDA, which could overstate sustainable margin.

Relevance 8/10Novelty 7/10Timing: after-hours and pre-week positioning following the guidance raise on Aug 5

Background

E.l.f. Beauty’s Rhode brand is now a dominant revenue contributor, and the company uses an ex-refund adjusted EBITDA normalization to present margins.

Company-level read

Ticker impact

$ELFBullishMedium confidence
Context

E.l.f. Beauty raised its fiscal 2027 sales-growth outlook after Rhode contributed about one-third of quarterly revenue and tariff refunds boosted margins.

Expected impact

Bias toward upside follow-through if investors focus on raised 2027 sales range, but expect volatility as the market questions sustainability of tariff-refund-driven margin gains.

Evidence & confidence

The article provides specific guidance changes (sales growth range 18% to 20% vs 12% to 14%) and quantifies Rhode’s revenue share (33.4%) and tariff-refund margin contribution (1,050 bps). It also flags a key vulnerability: legacy e.l.f. brand decline and uncertainty about recovery without refund tailwinds.

Market effects

Highlights how tariff refunds can materially distort adjusted margins for consumer beauty retailers, increasing scrutiny of ex-refund profitability.

No direct regional macro linkage beyond U.S. tariff/refund mechanics and planned European expansion.

Tariff-refund sensitivity may affect cross-border cost structures and margin comparability for global beauty brands.

Counterpoint

The guidance increase may be less durable if Rhode’s demand or tariff-refund benefits fade, while the legacy e.l.f. brand’s decline suggests underlying momentum issues.

Key entities

  • E.l.f. Beauty

    Raised fiscal 2027 outlook after Rhode accounted for 33.4% of quarterly revenue and tariff refunds boosted adjusted margins.

  • Rhode

    Generated about $160 million, representing 33.4% of quarterly sales, offsetting a decline in the namesake e.l.f. brand.

  • Tarang Amin

    CEO who stated the company is raising its fiscal 2027 outlook based on momentum.

  • Mandy Fields

    CFO describing overseas markets as a growth opportunity and noting Europe debut plans.

Related articles

$ELFMedAI 8/10

e.l.f. Beauty Q1 Earnings Call Highlights

e.l.f. Beauty (ELF) reported Q1 gross margin up 1,400 bps to 83%, aided by about $50M in IEEPA tariff refunds, and adjusted EBITDA up 93% to $168M. Adjusted net income rose to $105M, or $1.75/share. The company ended with $344M cash, repurchased $50M stock, and raised FY2027 outlook: adj. EBITDA $401M-$407M and adj. EPS $3.50-$3.55.

$ELFHighAI 9/10

e.l.f. Beauty Announces First Quarter Fiscal 2027 Results

e.l.f. Beauty reported first quarter fiscal 2027 results for the three months ended June 30, 2026. Net sales rose 36% to $479.4 million, with growth attributed to retailer and e-commerce channels. GAAP net income was $66.6 million and adjusted net income $104.6 million. The company raised its fiscal 2027 net sales outlook to 18% to 20% growth.

$ELFHighAI 9/10

E.l.f. Beauty Turns Tariff Windfall Into Global Growth Strategy

E.l.f. Beauty reported fiscal 2027 Q1 revenue of $479.4M, up 36% year over year, and adjusted EPS of $1.75, above analyst forecasts, and raised full-year guidance. The quarter ended June 30 included about $50M in tariff refunds plus interest after U.S. Supreme Court tariff rulings. Net income rose to $66.6M. Management plans to reinvest the refunds and expects FY revenue of $1.94B to $1.97B.

$GOOGLMed

Google's AI shake-up, tariff refunds, the interest rate outlook and more in Morning Squawk

CNBC Morning Squawk says Dow futures are mixed after five straight Dow gains. Fed officials including Neel Kashkari and Lisa Cook discussed a gradual rate rise as inflation work continues, alongside ADP payrolls. Alphabet shares fell 4% after AI leadership changes. The White House refunded about $100B in tariff revenue, including E.l.f. Beauty’s ~$50M. Bank of America CEO warned on leveraged markets. RBI beat Q2 expectations as Burger King same-store sales rose 8.5%.

$ELFMed

Why is e.l.f. Beauty stock sliding today?

e.l.f. Beauty (ELF) fell about 1.8% in pre-open after fiscal Q1 2027 results. The company reported adjusted EPS of $1.75 vs ~$0.73 consensus and revenue of $479.4M vs ~$430.8M, with gross margin up to 83% largely due to ~$50M one-time IEEPA tariff refunds. Organic net sales for the legacy e.l.f. brand declined in the high single digits. Guidance raised to FY27 net sales $1.94B-$1.97B and adjusted EPS $3.50-$3.55; analysts cited by Goldman and Bernstein.